ABSTRACT: The optimization of in-vitro culture conditions and the selection of the embryo(s) with the highest developmental competence are essential components in an ART program. Culture conditions are manifold and they underlie not always evidence-based research but also trends entering the IVF laboratory. At the moment, the idea of using sequential media according to the embryo requirements has been given up in favor of the use of single step media in an uninterrupted manner due to practical issues such as time-lapse incubators. The selection of the best embryo is performed using morphological and, recently, also morphokinetic criteria. In this review, we aim to demonstrate how the ART field may benefit from the use of microfluidic technology, with a particular focus on specific steps, namely the embryo in-vitro culture, embryo scoring and selection, and embryo cryopreservation. We first provide an overview of microfluidic and microfabricated devices, which have been developed for embryo culture, characterization of pre-implantation embryos (or in some instances a combination of both steps) and embryo cryopreservation. Building upon these existing platforms and the various capabilities offered by microfluidics, we discuss how this technology could provide integrated and automated systems, not only for real-time and multi-parametric monitoring of embryo development, but also for performing the entire ART procedure. Although microfluidic technology has been around for a couple of decades already, it has still not made its way into the clinics and IVF laboratories, which we discuss in terms of: (i) a lack of user-friendliness and automation of the microfluidic platforms, (ii) a lack of robust and convincing validation using human embryos and (iii) some psychological threshold for embryologists and practitioners to test and use microfluidic technology. In spite of these limitations, we envision that microfluidics is likely to have a significant impact in the field of ART, for fundamental research in the near future and, in the longer term, for providing a novel generation of clinical tools.
Introduction
ART have enhanced the chances for infertile couples to have a child of their own. Techniques such as in-vitro fertilization and intracytoplasmic sperm injection are now commonly and successfully used all over the world. The number of ART treatment cycles is still increasing (Kupka et al., 2016) , and only for the years 2008-2010 it is estimated that over 1.1 million ART babies were born (Dyer et al., 2016) . Common in both IVF and ICSI is the need for optimal culture conditions and, even more importantly, for a reliable approach for the selection of the 'best embryo(s)', i.e. with the highest developmental potential to result in a pregnancy and the birth of a healthy child. Culture conditions vary from lab to lab: embryos are cultured either individually or in groups, in microdrops of various volumes of medium (10-50 µl), which are mostly covered with mineral oil to restrict evaporation (Gardner et al., 2005; Balaban et al., 2014; Swain, 2015) . Culture is performed using either: (i) sequential media with change to a medium with a different composition proposed to follow the embryo's physiological needs; or (ii) single step media with refreshment, without change of the medium composition; or even, as recently suggested, (iii) single step media without any refreshment for uninterrupted embryo culture, especially for applications like time-lapse microscopy (Swain et al., 2016) . There is a long-lasting debate on how to choose the best culture conditions and medium indicating their advantages or disadvantages (for reviews, see Pool, 2004 Pool, , 2005 Lane and Gardner, 2007; Biggers and Summers, 2008; Machtinger and Racowsky, 2012; Quinn, 2012; Youssef et al., 2015; Swain et al., 2016) . However, there is no clear evidence of which type of media will support embryo development in a better way, and which culture conditions are the most appropriate. Notably, the overall culture conditions and media can never fully imitate the oviductal situation, and they will always be a more or less artificial environment supporting embryo development at their best.
Furthermore, we have to ask ourselves: What is a good embryo? What is 'the best' embryo (Bolton et al., 2015) ? Is it one that is morphological normal, one that divides equally (Kirkegaard et al., 2015) or one that is metabolically silent (Leese, 2012) ? The final aim is to have one (or more) embryo(s) with the highest developmental competence and highest chance of successful implantation and development after transfer. A variety of approaches for embryo grading have been proposed so far, as reviewed recently (Montag et al., 2013; Bolton et al., 2015) . In the most commonly used strategy, morphological features are examined and embryos are evaluated at defined time points during pre-implantation development in a standardized manner, as suggested by the European Society of Human Reproduction and Embryology (ESHRE) and the Alpha (scientists in reproductive medicine) (Balaban et al., 2011) . In recent years, time-lapse imaging systems have entered the market as an alternative approach for continuous embryo monitoring and scoring during the in-vitro culture period without removing the embryo from the incubator (Lemmen et al., 2008; Hlinka et al., 2012; Conaghan et al., 2013; Kirkegaard et al., 2013 , and for a review, see Kirkegaard et al., 2015) . Using these systems, new morphological and dynamical parameters, so-called morphokinetic features, have been derived (Wong et al., 2010; Meseguer et al., 2011; Campbell et al., 2013; Conaghan et al., 2013) and correlated to implantation success (Meseguer et al., 2011; Dal Canto et al., 2012; Rubio et al., 2014; VerMilyea et al., 2014; Kirkegaard et al., 2015) . However, it is worth mentioning that it is a matter of critical debate whether these sophisticated imaging systems have a true benefit for embryo selection (Kaser and Racowsky, 2014; Armstrong et al., 2015; Racowsky et al., 2015) . Finally, the metabolism of the pre-implantation embryos is receiving attention for assessment of the embryo developmental competence in a more objective and non-invasive way (Gardner and Wale, 2013) . Metabolic measurements examine alterations in the microenvironment of the embryo for specific parameters to yield information on the physiological status of the embryos. Two approaches dominate metabolic measurements: (i) the examination of specific metabolites (e.g. oxygen (Houghton et al., 1996) , amino acids (Houghton et al., 2002) , glucose (Gardner and Leese, 1987; Hardy et al., 1989) , lactate (Hardy et al., 1989) , leptin (Gonzalez et al., 2000) , and sHLA-G (Fuzzi et al., 2002) ) and (ii) the analysis of spent culture medium to create a fingerprint using either NIR-spectroscopy (Vergouw et al., 2008) or mass spectrometry (Katz-Jaffe and McReynolds, 2013) . Solely metabolism-based scoring strategies have not made it yet to the clinics due to conflicting results on the validity of certain metabolic parameters, a lack of user-friendly protocols and a high technicality of the associated instrumentation (Nel-Themaat and Nagy, 2011). Although single morphological and metabolic parameters aid in selecting the embryo(s) with a high developmental potential, either they may be merely subjective or their results are difficult to interpret. Ideally, new approaches and platforms are desired for non-subjective and multiparametric assessment of embryo developmental competence throughout its development. Similarly, automation is very important and also required in ART labs, not only if multiple characterization parameters have to be recorded at different time points through the embryo development, meaning an increase in workload, but also to avoid subjective decisions regarding embryo selection and transfer. Therefore, ideally, pre-implantation culture and embryo characterization should be combined in one single and automated platform. These different aspects of multi-parametric measurements, automation and combined culture and characterization can be fulfilled by using microfluidic technology, which allows the development of complex, integrated, parallelized and autonomous culture and analytical platforms. Finally, if more high-quality embryos are available than necessary for transfer in utero, the remaining embryos are cryopreserved for longterm storage. This step can benefit as well from the use of microfluidics, which can provide reliable and automated tools and protocols for embryo vitrification, as discussed later in this article. Table I summarizes the key features offered by microfluidics. Some of those, which are of particular interest for the field of ART, and especially for the culture, characterization and cryopreservation of embryos, are discussed in more detail in various sections of this review.
In this review, we aim at presenting microfluidic developments in the last 15 years for the manipulation of mammalian embryos. We specifically review miniaturized devices developed for (i) in-vitro preimplantation culture of embryos, (ii) characterization of embryos, not only for monitoring embryo growth during the culture, but also for scoring purposes and selection before transfer and finally (iii) embryo cryopreservation. Next, we elaborate on the possibilities offered by microfluidics to develop integrated and automated platforms combining multiple in-vitro steps of the entire ART protocol. Following this, we discuss why microfluidics, while being highly interesting for ART labs, has not made it yet into clinical routine, which technological and psychological thresholds have to be overcome, and which validation steps must be performed, before this happens. Finally, we discuss potential applications of integrated microfluidic platforms for fundamental research as well as their potential as clinical devices for use in a more long-term future.
Microfluidic technology for the culture of mammalian embryos
Microfabricated and microfluidic platforms for in-vitro culture of embryos Embryo culture is one of the aspects of the ART protocol that has been explored the most in a miniaturized and/or microfluidic format, and a great variety of microfabricated platforms have already been proposed (see Table II and Fig. 1 for selected examples) . A first category of devices consists of microwell arrays, whose ancestor is the well-of-the-well (WoW) device (Vajta et al., 2008) . In this configuration, individual embryos are isolated in independent microwells, but they still communicate with each other through an excess of culture medium (a few microliters) also covered with mineral oil. Microwell arrays have been integrated in microfluidic devices, in which semen was delivered through microchannels for in-situ fertilization prior to pre-implantation culture (Fig. 1A) (Han et al., 2010; Ma et al., 2011) . Next to this, hybrid systems combining meso-and microscale structures and using microliter-sized droplets have been reported. In one device, pre-implantation embryos were cultured in a conventional 10-μl droplet of medium in a funnel structure, which was connected to a microfluidic network equipped with an integrated micropump to provide embryos with fresh growth medium in a pulsatile way (Heo et al., 2010) . Still revisiting the droplet format, dynamic culture has been demonstrated in an EWOD (electrowetting-on-a-dielectric) platform with on-demand displacement of a 1-μl droplet that contained the pre-implantation embryo(s) (Fig. 1B) (Huang et al., 2015) . Finally, a number of fully microfluidic devices have been reported (Fig. 1C-E) , in which embryos were cultured in microchannels (Hickman et al., 2002; Raty et al., 2004; Kim et al., 2009) or nanoliter microchambers (Melin et al., 2009; Esteves et al., 2013; Kieslinger et al., 2015) , and possibly secured with the help of dam structures (Hickman et al., 2002; Raty et al., 2004) , grids (Esteves et al., 2013) or valves (Melin et al., 2009 ).
Confinement and dynamic environment
One of the primary motivations for using microfluidic technology for the pre-implantation development of embryos was the possibility to accurately control the culture conditions through the use of a confined and dynamic environment.
Confinement allows fine-tuning of any physical and chemical parameter in the in-vitro embryo microenvironment. Furthermore, by confining one or multiple embryo(s) in a sub-microliter volume of medium, high concentrations of autocrine and paracrine factors, which are postulated to support embryo development (Paria and Dey, 1990) , can be created locally in close proximity of the embryo(s). However, such small volumes suffer from evaporation issues, leading to changes in osmolality and concentrations in the culture medium. Microfluidics solves these evaporation issues since culture devices are entirely closed. Taking advantage of this capability, Esteves et al. (2013) successfully achieved single murine embryo development in a nanoliter chamber (Fig. 1D) . While single mouse embryo development is normally impaired in microliter droplets due to a lack of growth factors (Paria and Dey, 1990) , they hypothesized that in their system autocrine and paracrine factors were accumulating in the direct embryo vicinity to promote its growth (Esteves et al., 2013) .
The unique flow properties found at the microscale facilitate the implementation of dynamic culture conditions to bring fresh nutrients, while removing toxic substances produced by embryos such as ammonia, without any embryo manipulation and risk of endangering them. Furthermore, under dynamic culture, embryos can be exposed to mechanical stimulation, as occurs in vivo in the oviductal surrounding, which has been reported to positively influence their development (Fauci and Dillon, 2006) . So far, microfluidic embryo culture has mostly been limited to static conditions. For instance, embryos have been kept in culture in closed nanoliter chambers (Melin et al., 2009) or in open structures (Raty et al., 2004; Han et al., 2010; Ma et al., 2011; Esteves et al., 2013; Kieslinger et al., 2015) . Interestingly, it should be noted that the latter open configuration still allows for creating a pseudo-dynamic environment with continuous diffusion-based delivery of fresh nutrients from the device reservoirs to the surroundings of the embryo(s). Still, several attempts for dynamic culture have been reported: by perfusing medium with a constant flow rate in a microchannel (Hickman et al., 2002) ; through continuous medium delivery in a 10-μl droplet using an integrated peristaltic pump (Heo et al., 2010) ; by changing the medium once in a nanoliter chamber (Esteves et al., 2013) using passive pumping (Walker and Beebe, 2002) ; by placing the microdevice on a tilting stage to initiate the displacement of embryos through a microchannel equipped with constrictions imitating the oviduct (Kim et al., 2009) ; and, finally, by moving periodically conventional 1-μl droplets of culture medium on an array of electrodes 
EWOD, electrowetting-on-a dielectric; PDMS, polydimethylsiloxane; PS, polystyrene; Pt, platinum; Si, Silicon; Ti, titanium; WoW, well-of-the-well.
using EWOD (Huang et al., 2015) . Interestingly, reported dynamic culture studies have yielded very different results depending on the way the medium was refreshed and dynamic culture was implemented. Embryo development was impaired under continuous medium flow, this being attributed to a too high applied flow rate (0.1-0.5 μl/h) (Hickman et al., 2002) . Furthermore, bovine embryos cultured in an oviduct-like channel lost their viability before reaching the blastocyst stage (Kim et al., 2009) . On the contrary, punctual (Esteves et al., 2013) and pulsatile delivery of medium (Heo et al., 2010) , or periodic actuation of a culture droplet (Huang et al., 2015) seemed to promote embryo growth, in terms of both pre-implantation development and fetal rates.
Single embryo culture
Pre-implantation culture of embryos is preferably performed at the single embryo level to avoid the negative influence of degenerating embryos (Spindler and Wildt, 2002) . In microfabricated and microfluidic structures, the pre-implantation culture can easily be downscaled to the single embryo level in a nanoliter volume. This approach is particularly advantageous to eventually follow the development of each individual embryo either using time-lapse imaging or through analysis of the culture medium, but also to fine-tune the embryo microenvironment according to its needs (Rienzi et al., 2011) . A first platform in which embryos are isolated in individual sub-microliter wells is the microwell array format or WoW device ( Vajta et al., 2008) . In microwell arrays, embryos still communicate with each other so that embryo tracking is restricted to imaging approaches and this format precludes customization of the culture conditions for individual embryos cultured in the same platform. Interestingly, in one device oil was added exactly on the top of the microwell array to truly isolate each individual embryo in individual microwells (Komori et al., 2012) . In an alternative approach, demonstrated on sea star embryos so far (and non-fertilized human oocytes), dedicated pockets were placed in a microchannel to trap individual embryos, and their development was successfully monitored in situ using time-lapse imaging (Angione et al., 2015) . Here again, embryos were able to communicate with their pairs through the culture medium. In most of the microfluidic platforms, embryos have been cultured as groups, using at least 10 embryos (Hickman et al., 2002; Raty et al., 2004; Han et al., 2010; Heo et al., 2010; Ma et al., 2011) , or a couple of embryos (Melin et al., 2009) , and only a few devices have been tested at the single embryo level, with individual embryos trapped in sub-microliter chambers (Esteves et al., 2013; Kieslinger et al., 2015) or in a 1-μl droplet (Huang et al., 2015) .
Microfluidics for the selection of mammalian embryos
A number of approaches and parameters have been reported to examine the developmental competence of pre-implantation embryos (Montag et al., 2013) . Among all these different strategies and parameters, two approaches have been explored in miniaturized devices: (i) assessing embryo metabolism (embryo oxygen consumption and substrate utilization) or (ii) using morphokinetic parameters derived from time-lapse imaging.
Metabolic measurements
Dedicated sensors or specific analytical modules can be integrated in microfluidic devices for in-situ monitoring of specific metabolic parameters. Alternatively, microfluidic devices can be interfaced to spectroscopic techniques such as mass spectrometry (Le Gac et al., 2004; Wang et al., 2015) for online molecular profiling measurements. Finally, it is worth noticing that a microfluidic format is particularly attractive for metabolic measurements: since embryos are cultured in a sub-microliter volume of medium, the metabolic activity of embryos, or even of one single embryo, can induce relatively large variations in the medium composition in the close vicinity of the embryo(s).
Oxygen consumption
Oxygen consumption, which has been one of the first parameters examined to characterize embryo metabolism (Mills and Brinster, 1967; Houghton et al., 1996) , reflects the overall metabolic activity. The embryo oxygen consumption is determined indirectly by monitoring variations in the dissolved oxygen concentration in medium in the vicinity of the embryo(s) using either electrochemical (Shiku et al., 2004; Lopes et al., 2007) or optical means (Houghton et al., 1996; O'Donovan et al., 2006) , and both detection strategies have been implemented in microfabricated and/or microfluidic devices.
The electrochemical approach was initially demonstrated at the single embryo level in a microwell array using an external microelectrode (i.e. a miniaturized Clark electrode (Lopes et al., 2007) or a scanning electrochemical microscopy (SECM) tip (Shiku et al., 2004) ). Specifically, the oxygen consumption of bovine (Shiku et al., 2004) , mouse (Lopes et al., 2007) as well as human embryos (Abe et al., 2008) was derived from the oxygen concentration profile measured around the embryo using the spherical diffusion theory. It is worth noticing that a system using a miniaturized Clark electrode, the Nanorespirometer™, has been commercialized (Unisense, Aarhus, Denmark), but it has never been introduced into clinical routines, since the same microelectrode was used for embryos of several patients, which is associated with potential contamination issues. On the contrary, in a microfluidic format, the oxygen sensor is integrated in the bottom substrate of the device, in which the embryo is placed and possibly cultured, which suppresses any risk of cross-contamination. For instance, Wu et al. (2007) employed a series of four independent microelectrodes placed at different distances from a bovine embryo to characterize the oxygen concentration gradient resulting from its respiratory activity, and to subsequently assess its oxygen consumption ( Fig. 2A) . The same group later reported a ring-shaped electrochemical sensor integrated in a PDMS conical microwell (Date et al., 2011) ; individual mouse embryos were placed in the center of the ring sensor in a micropit structure, and their oxygen consumption was successfully measured at different developmental stages.
Alternatively, changes in the dissolved oxygen concentration can be followed in real time using oxygen-sensitive phosphorescent probes based on transition metal complexes (Ruggi et al., 2011, Papkovsky and Dmitriev, 2013) , a strategy that has also been applied to assess the oxygen consumption of mammalian embryos. For instance, a commercially available water-soluble oxygen-sensitive probe was added to the culture medium to follow the oxygen consumption of groups of 5-20 mouse embryos at different developmental stages (2-cell and blastocyst stages) during 1 h in a microfluidic device (O'Donovan et al., 2006) . Similar Platinum-porphyrin-based oxygen-sensitive dyes were encapsulated in a polymer material (polystyrene), which was patterned in the form of a thin-film sensor at the bottom of a microwell array culture device (Komori et al., 2012) . Mouse embryos were cultured for 4 days in this device and concomitantly assessed using morphologic criteria and their oxygen consumption, to select high-quality blastocysts for transfer.
Substrate turnover
The three basic substrates glucose, pyruvate and lactate are also examined to study the pre-implantation embryo metabolism Lane and Gardner, 2000) . Pyruvate, and at later embryonic stages, glucose represent the main sources of energy for the embryo during the pre-implantation period and their consumption is associated with the production of lactate. These three energetic substrates are analyzed by quantifying secondary products of an enzymatic reaction, and different classes of enzymes used for the substrate degradation give rise to different types of secondary products. Using dehydrogenases, fluorescent probes such as NAD(P)H are produced so that substrates are quantified based on the NAD(P)H fluorescence intensity. Spent culture medium was mixed in nanoliter-loop reactors in a microsystem (Fig. 2B) together with an enzymatic cocktail to quantify substrate utilization by individual embryos (Urbanski et al., 2008) . This study notably revealed a significant discrepancy in the metabolic pattern of 10 individual mouse embryos, which were morphologically identical (Fig. 2B) . Substrate degradation by oxidases is accompanied by the generation of H 2 O 2 , which can be in turn detected either directly by amperometry (Yao et al., 2004) or indirectly by fluorescence after a second enzymatic reaction. Using this second strategy, the glucose consumption of groups or individual mouse embryos cultured in a microfunnel structure was continuously monitored during >8 h (Heo et al., 2012) . Here, the second enzymatic reaction catalyzed by horseradish peroxidase produced a fluorescent species, resorufin, which was quantified to derive the initial concentration in glucose. The platform proposed for these measurements was actually an extension of the culture device developed by the same group (Heo et al., 2010) . For each measurement, culture medium (~100 nl) was sampled out of the culture microfunnel using an integrated micropump and redirected to a microfluidic channel where the enzymatic assays took place.
Time-lapse imaging
Microfluidic devices are mostly made from optically transparent materials, so that they lend themselves well to time-lapse imaging throughout the embryo pre-implantation culture (Fig. 2C) . So far, this microfluidics-time-lapse combination has mostly been explored using a microwell array format, using bovine (Sugimura et al., 2010) and mouse (Chung et al., 2015) embryos as well as donated surplus human embryos (Hashimoto et al., 2012) . For instance, Chung et al. (2015) successfully determined two parameters (i.e. 4-cell cleavage and 8-cell cleavage timings) to identify mouse embryos with a high developmental competence that gave rise to viable offspring after embryo transfer. In another study using donated human embryos, two specific kinetic parameters in the pre-implantation development of individual embryos (i.e. time required to complete the second and third divisions) were examined. In this latter study, various populations of embryos were compared, i.e. ICSI versus IVF embryos, and embryos cryopreserved using different methods (slow freezing versus vitrification) (Hashimoto et al., 2012) .
Microfluidics for embryo cryopreservation
Cryopreservation is necessary for long-term storage of surplus good quality embryos, which can possibly be transferred later after thawing (so-called, frozen embryo transfer or FET). Both possible protocols for cryopreservation, slow freezing or vitrification, use cryoprotectants to omit damaging ice crystal formation in the cytoplasm of either oocytes or cells of the developing embryo (Pegg, 2010) . For slow freezing, dedicated equipment is required to accurately control the gradual reduction in temperature in a time-controlled manner. Vitrification, on the contrary, is a much faster technique, which is however technically more sophisticated as it relies on precise exposure times to increased concentrations of the cryoprotective solution, followed by quick freezing in liquid nitrogen (Alminana and Cuello, 2015) . Vitrification, which is now perhaps the most commonly used technique, greatly benefits from the use of small volumes, which increases the chance of successful 'freezing' while reducing the risk of fractures (Arav, 2014) , a requirement that can easily be fulfilled using microfluidic devices. Another key-asset brought by microfluidics is the potential to accurately control the flow and to gradually change the cryoprotectant amount in the solution in an automated way, without manipulating and endangering the embryo and without the need for highly skilled personnel (Song et al., 2009) . A few examples of microfluidic platforms for oocyte and embryo cryopreservation using vitrification have been reported in the literature (Heo et al., 2011; Pyne et al., 2014; Lai et al., 2015) . For instance, using digital microfluidics, Pyne et al. (2014) accurately timed the exposure of a single mouse embryo placed in a sub-microliter droplet to various cryoprotectant and washing solutions. Thereby, they successfully demonstrated that the whole process of vitrification could be entirely automated, with similar results compared with manual procedures and a significantly decrease in the labor cost (Pyne et al., 2014) . Another device of particular interest is the 'Gavi system', which uses closed microfluidic channels, and which therefore allows controlled and progressive solution exchanges in a reservoir, the 'pod', in which a single embryo is placed (Roy et al., 2014) . Using 'Gavi', similar promising results toward the automation of the whole vitrification process were reported, using not only mouse embryos but also donated human embryos (Roy et al., 2014) .
The future of microfluidics for ART
This last section is dedicated to the role microfluidics is likely to play in the field of ART in the near or longer-term future. Building upon existing microfluidic platforms and the capabilities offered by this technology, we first elaborate on what could come next, and we further discuss what is hampering, to our opinion, the implementation of microfluidics into the clinics.
Toward a multi-functional stand-alone integrated platform
Embryo pre-implantation culture and characterization Although the number of microfabricated and microfluidic devices for in-vitro culture of pre-implantation mammalian embryos has been increasing, arguably, some of the promising characteristics of the micrometer scale have not yet been entirely explored: embryos are still mostly cultured in groups, in large amounts of medium (in the microliter range) and mostly under static conditions. In terms of dynamic culture, medium with a constant composition has been perfused continuously or in bursts, while some in-vitro culture protocols require a single change in the medium composition on the third day (Schwarzer et al., 2012; Hemkemeyer et al., 2014; Schulte et al., 2015) . Interestingly, using microfluidic technology, this change could be accomplished gradually including, if necessary, a pH adaption due to medium requirements, as happens in vivo, to closely follow the developmental stages of the embryo. Furthermore, for a more accurate control of the temperature and the gas tensions (O 2 , CO 2 ) in the immediate vicinity of the embryos, a dedicated miniaturized incubator (Harink et al., 2014) could be developed in which the microfluidic culture platforms could be inserted (Fig. 3) , and separate miniaturized incubators would be used for different patients. In this configuration, all culture parameters including the medium composition could be optimized for each patient, taking also into account, e.g. the age of the patient or the oocyte quality, as well as data acquired via time-lapse imaging and metabolic analysis. Thereby, the ART treatment could be fully customized and personalized, depending on the patient's profile and physiological needs of the embryo. Equally important, negative conditions coming from intrinsic problems of the mother, which might lead to problems in the oocyte or embryo, could be corrected through individualized culture, to eventually yield healthy embryos.
A logical step is to integrate pre-implantation embryo culture and characterization for real time and in-situ monitoring of embryo development during the in-vitro culture period in one single platform. While this combination has already been reported for time-lapse imaging, ideally, multiple parameters should be measured simultaneously to yield a comprehensive picture of the embryo's fitness, which is essential for proper embryo selection and to increase success rates. Recently, it has been shown that combining morphological examination through time-lapse imaging and oxygen consumption measurements allowed knowledge on the developmental competence of the embryo to be gained, eventually identifying more complete selection criteria for embryo selection before transfer (Tejera et al., 2016) . Using microfluidics, arguably even more information could be collected through, for instance, metabolic measurements to yield a comprehensive picture of the embryo's developmental potential. For instance, specific sensors and analytical modules could be integrated in the platform in the direct vicinity of the embryo culture chamber, or/and through coupling of the platform to larger analytical equipment (e.g. MS, NIR or HPLC) to access simultaneously multiple parameters (Fig. 3) . Furthermore, additional analytical schemes to those already mentioned in the previous sections could be implemented in a microfluidic format for characterizing the embryo metabolism. Amino acid (AA) profiling is a well-established strategy for embryo scoring and sexing (Houghton et al., 2002; Sturmey et al., 2010) . AA analysis is usually performed off-line using HPLC and fluorescence detection and spent culture medium (Houghton et al., 2002) . Arguably, capillary electrophoresis (CE), which is the first separation technique that has been implemented in a microfluidic format, is equally suited for AA analysis (Pumera, 2007) . Furthermore, CE can be directly integrated in the culture device for online AA analysis in the culture medium, as recently demonstrated by monitoring AA secretion profiles of islets of Langerhans cultured in a microfluidic device (Wang et al., 2016) .
Full ART protocol on a chip?
Using a microfluidic format, the in-vitro ART steps may be revisited, with embryos being manipulated individually in sub-microliter volumes of medium without any risk of medium evaporation. All these steps may be integrated in one single platform, from gamete characterization and selection all the way until embryo selection before transfer (Fig. 3) . While various steps of the protocol have been demonstrated in separate microfluidic platforms (i.e. semen analysis (for a review, see Knowlton et al., 2015) , oocyte characterization (Zeggari et al., 2007; Wacogne et al., 2008) , removal of the cumulus cells (Zeringue et al., 2005a (Zeringue et al., , 2005b , fertilization (Suh et al., 2006; Han et al., 2010; Ma et al., 2011) , embryo culture and embryo characterization), only a few platforms have successfully combined two steps or more of the complete treatment (see Table II ). Using fully integrated platforms, the manipulation of the gametes and embryos would also be minimized, along with human intervention and herewith associated risks of errors and contamination. Moreover, the use of integrated, and possibly fully automated platforms to perform the whole ART protocol in a nonsubjective way, would lead to standardization of the treatment across laboratories and eventually enhance subsequent success rates (Meseguer et al., 2012) . Furthermore, some techniques, which are routinely used in ART laboratories could benefit from the use of a microfluidic format, like the identification of viable but immotile sperm (Nordhoff, 2015) or the fertilization by ICSI. For ICSI, microfluidic technology would provide enhanced control, on one hand, on oocyte manipulation to guide it to an integrated needle, as already demonstrated for somatic cells (Adamo and Jensen, 2008) , and, on the other hand, on the (automated) injection of one spermatozoon into the oocyte, possibly after its on-chip selection (Fig. 3) . Similarly, biopsy needles could be secured in a microdevice for the isolation of one or a few cells from cleavage or blastocyst stage embryos (Fig. 3) , aiming at further analysis. The isolated cell(s) could subsequently be transferred to a separate compartment in the same platform for molecular or (epi)genetic analysis, since microfluidics has proven to be ideally suited for the manipulation and analysis of individual and rare cells . Alternatively, fluid could be extracted from the blastocoel and similarly analyzed online in the microfluidic device.
Microfluidic technology for ART: a critical evaluation
While the merits of microfluidics have been praised for about three decades, in the field of ART as well as in other fields, one could argue that the revolution promised by this technology is not there yet. In fact, no IVF center or clinic worldwide actually uses microfluidic technology in their daily routines. We have to ask ourselves: why?
First of all, new technologies normally take years or even longer depending on their feasibility before they are introduced into ART daily routines. New technologies must indeed first be thoroughly validated using animal models, followed by spared human embryos, and finally, through randomized clinical trials (Harper et al., 2012) . Furthermore, and maybe more importantly, embryologists must accept these new technologies and be convinced of their superior performance compared with previous procedures and technologies. Figure 3 The vision. Fully integrated microfluidic platform for ART: (i) where individual oocytes can be trapped using dedicated microstructures, fertilized in situ via either IVF or ICSI (orange-framed pictures, top left); (ii) where the resulting embryos are cultured during pre-implantation in nanoliter volumes, possibly under dynamic conditions (green-framed pictures); and (iii) embryos are assessed throughout their development using multiple parameters, through time-lapse imaging, using dedicated sensors integrated in the culture chamber, based on genetic analysis after blastocyst biopsy, or through molecular analysis using spent culture medium (off-line) (blue-framed picture). Each microfluidic platform is dedicated to one specific patient and comprises multiple chambers for the treatment of multiple oocytes/embryos in parallel; all platforms are inserted in a miniaturized incubator for precise control on the temperature and gas tension (center picture). Introducing new technologies in a laboratory implies a rupture in daily practices, with a change in the treatment procedures and new training of the employees. A typical example was the introduction of timelapse incubators. In the beginning, only a few laboratories would use time-lapse imaging. However, after extremely positive reports were presented at congresses and the corresponding papers were published, it has become a hype and now many laboratories have implemented this technology into their clinical routine.
This psychological threshold may be even more pronounced for microfluidics which can be considered as a 'disruptive technology' (Becker, 2009) , which means that its implementation to replace previous technologies requires significant changes in a laboratory infrastructure and practices. As a consequence, the acceptance of disruptive technologies and their uptake by the targeted market are considerably slower, which may explain why microfluidics has not reached yet the clinical market in the field of ART.
Furthermore, microfluidic research is mostly taking place in an academic environment, and concerns a limited number of industrial partners (Becker, 2010) . As a consequence, choices made at an early stage of device development may be suitable for academic research, while not being adapted for commercialization purposes and the development of products. For instance, this gap between academic research and commercialization is particularly noticeable when it comes to the materials used for the fabrication of the microfluidic devices. Most of the microfabricated and microfluidic platforms meant for embryo culture and characterization have been fabricated from polydimethylsiloxane (PDMS) (see Table II ). While this highly popular elastomer material has proven not to be toxic to embryos (Raty et al., 2004; Esteves et al., 2013) , it raises more and more concerns, and its biocompatibility is contested (Berthier et al., 2012) . PDMS is also a hydrophobic material, which is an obstacle for commercial purposes. Furthermore, soft lithography, the fabrication technique of PDMS devices, is not amenable to large-scale production, as ultimately required for commercialization. In contrast, most of the commercial culture dishes are based on other polymer materials such as polystyrene, which have been fully characterized for their safe use with embryos and which can easily be sterilized for single use. Devices and platforms for ART must be of medical grade, and they must get certification for their possible clinical use, a process that would be facilitated when using already approved materials in the ART field.
To our opinion, a number of specific requirements are essential before microfluidic technology reaches the clinics. On one hand, it must first show superior performance compared with current protocols and practices as well as true clinical benefit. On the other hand, it must prove its practicality, including user-friendliness and easy interface as well as automation.
The first aspect, which is the superiority in terms of performance of microfluidics, is still to be demonstrated to our opinion. So far, almost all platforms that have been discussed in this review have merely been tested on animal models, and mostly murine and bovine embryos (see Table II ). Mouse embryos indeed represent the first choice when it comes to assess new devices, culture medium and technologies for ART (Gardner et al., 2005) , although they are physiologically very different from human embryos. However, as for any new technology introduced in the field of ART, as mentioned earlier, microfluidic devices need to be further validated on donated human embryos, as well as through randomized clinical trials (Harper et al., 2012) . Arguably, the way to the clinics for all these devices is still likely to be long, since only a few devices have actually been assessed on human embryos, which were still surplus donated embryos (Hashimoto et al., 2012; Kieslinger et al., 2015) . Importantly, more interactions are required between engineers and embryologists and practitioners, not only for this extended characterization, but also to ensure that engineers include in their product design the practical needs of the laboratory personnel.
Automation of the platforms, which is one of the key-promises of microfluidic technology, is particularly essential for standardization of the processes in the IVF labs (Rienzi et al., 2011; Meseguer et al., 2012) . However, almost all devices reported so far are handled manually, and their use requires skilled personnel, who have followed dedicated training in engineering. As mentioned earlier, most of the microfluidic developments for ART are taking place in an academic environment as a result of a collaboration between two academic partners: an engineer who designs and fabricates the microfluidic device(s) and a biologist or embryologist who is in charge of the device validation using embryos. What is missing here is a third party, an expert in instrumentation, or an industrial to develop a user-friendly and automated interface around the microfluidic device, and to eventually yield a turn-key system, as required for use in clinical practices. A few platforms, which are semiautomated and more user-friendly, are still worth mentioning. For instance, of particular interest is one device that includes a peristaltic pump allowing, without pipetting or any manual intervention, continuous delivery of medium to the embryos (Heo et al., 2010) , and possible retrieval of spent medium toward its analysis for specific metabolic markers (Heo et al., 2012) . More recently, an automated interface has been developed to pilot the entire embryo in-vitro culture in six independent chambers, with controlled medium delivery, possible changes in the medium composition, and in-situ regulation of the temperature and gas tension (Perozziello et al., 2012) . These first examples actually confirm the potential of microfluidic technology for automation of the culture and characterization of the embryos, which represents an essential milestone toward standardization of these steps, and eventually of the entire protocol.
For all these reasons, we believe that the primary niche for microfluidic technology in the field of ART in the next coming years is for basic research. For this purpose, miniaturized platforms combining different capabilities for embryo culture and characterization, also without any automated interface, are of great interest. For instance, platforms allowing real-time and multi-parametric monitoring of embryos would be instrumental in screening various physical or chemical culture parameters and optimizing the medium composition. Furthermore, such integrated platforms are very likely to provide more fundamental knowledge on embryo development, which could in turn benefit clinical treatments, and help in identifying the best embryos leading to more successful and healthy pregnancies. 
